These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26586684)

  • 21. Prognostication in Home-Dwelling Patients with Advanced Dementia: The Palliative Support DEMentia Model (PalS-DEM).
    Hum A; George PP; Tay RY; Wu HY; Ali NB; Leong I; Chin JJ; Lee A; Tan L; Koh M
    J Am Med Dir Assoc; 2021 Feb; 22(2):312-319.e3. PubMed ID: 33321077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic model for patients with advanced cancer using a combination of routine blood test values.
    Miyagi T; Miyata S; Tagami K; Hiratsuka Y; Sato M; Takeda I; Kohata K; Satake N; Shimokawa H; Inoue A
    Support Care Cancer; 2021 Aug; 29(8):4431-4437. PubMed ID: 33443662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of the Palliative Prognostic Score With or Without Clinicians' Prediction of Survival in Patients With Far Advanced Cancer.
    Yoon SJ; Suh SY; Hui D; Choi SE; Tatara R; Watanabe H; Otani H; Morita T
    J Pain Symptom Manage; 2021 Jun; 61(6):1180-1187. PubMed ID: 33096217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.
    Miura T; Matsumoto Y; Hama T; Amano K; Tei Y; Kikuchi A; Suga A; Hisanaga T; Ishihara T; Abe M; Kaneishi K; Kawagoe S; Kuriyama T; Maeda T; Mori I; Nakajima N; Nishi T; Sakurai H; Morita T; Kinoshita H
    Support Care Cancer; 2015 Nov; 23(11):3149-56. PubMed ID: 25777319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter?
    Hamano J; Yamaguchi T; Maeda I; Suga A; Hisanaga T; Ishihara T; Iwashita T; Kaneishi K; Kawagoe S; Kuriyama T; Maeda T; Mori I; Nakajima N; Nishi T; Sakurai H; Shimoyama S; Shinjo T; Shirayama H; Yamada T; Morita T
    Cancer; 2016 May; 122(9):1453-60. PubMed ID: 27018875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective Validation of the Objective Prognostic Score for Advanced Cancer Patients in Diverse Palliative Settings.
    Jho HJ; Suh SY; Yoon SJ; Lee SS; Ahn HY; Yamaguchi T; Mori M; Maeda I; Baba M; Morita T
    J Pain Symptom Manage; 2016 Sep; 52(3):420-7. PubMed ID: 27387346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying prognostic factors for survival in advanced cancer patients: a prospective study.
    Lam PT; Leung MW; Tse CY
    Hong Kong Med J; 2007 Dec; 13(6):453-9. PubMed ID: 18057434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer.
    Cheng L; DeJesus AY; Rodriguez MA
    J Pain Symptom Manage; 2017 Apr; 53(4):720-727. PubMed ID: 28062337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the accuracy of clinicians' prediction of survival and Palliative Prognostic Score: an East Asian cross-cultural study.
    Hiratsuka Y; Yoon SJ; Suh SY; Choi SE; Hui D; Kim SH; Lee ES; Hwang SW; Cheng SY; Chen PJ; Mori M; Yamaguchi T; Morita T; Tsuneto S; Inoue A
    Support Care Cancer; 2022 Mar; 30(3):2367-2374. PubMed ID: 34743238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care.
    Pirovano M; Maltoni M; Nanni O; Marinari M; Indelli M; Zaninetta G; Petrella V; Barni S; Zecca E; Scarpi E; Labianca R; Amadori D; Luporini G
    J Pain Symptom Manage; 1999 Apr; 17(4):231-9. PubMed ID: 10203875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis prediction with two calculations of Palliative Prognostic Index: further prospective validation in hospice cancer patients with multicentre study.
    Subramaniam S; Dand P; Ridout M; Cawley D; Miller S; Valli P; Bright R; O'Neill B; Wilcocks T; Parker G; Harris D
    BMJ Support Palliat Care; 2019 Sep; 9(3):326-331. PubMed ID: 29507041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?
    Zhao W; Wang P; Jia H; Chen M; Gu X; Liu M; Zhang Z; Cheng W; Wu Z
    BMC Cancer; 2017 Aug; 17(1):514. PubMed ID: 28768490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein and white blood cell count are adverse prognostic markers for patients with advanced cancer on parenteral nutrition in a palliative care unit setting: A retrospective cohort study.
    Kieler M; Kössler P; Milovic M; Meyer E; Križanová K; Kum L; Friedrich A; Masel E; Bauer R; Unseld M
    Palliat Med; 2022 Mar; 36(3):540-548. PubMed ID: 35184630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting survival in patients with advanced disease.
    Glare P; Sinclair C; Downing M; Stone P; Maltoni M; Vigano A
    Eur J Cancer; 2008 May; 44(8):1146-56. PubMed ID: 18394880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of Modified Models of Objective Prognostic Score in Patients With Advanced Cancer.
    Yoon SJ; Suh SY; Hiratsuka Y; Choi SE; Kim SH; Koh SJ; Park SA; Seo JY; Kwon JH; Park J; Park Y; Hwang SW; Lee ES; Ahn HY; Cheng SY; Chen PJ; Yamaguchi T; Tsuneto S; Mori M; Morita T
    J Palliat Med; 2023 Aug; 26(8):1064-1073. PubMed ID: 37200448
    [No Abstract]   [Full Text] [Related]  

  • 37. Palliative Performance Scale Score at 1 Week After Palliative Care Unit Admission is More Useful for Survival Prediction in Patients With Advanced Cancer in South Korea.
    Yoon SJ; Choi SE; LeBlanc TW; Suh SY
    Am J Hosp Palliat Care; 2018 Sep; 35(9):1168-1173. PubMed ID: 29660991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical decision support tool to predict survival in cancer patients beyond 120 days after palliative chemotherapy.
    Ng T; Chew L; Yap CW
    J Palliat Med; 2012 Aug; 15(8):863-9. PubMed ID: 22690950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists.
    Yamada T; Morita T; Maeda I; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Ono S; Ozawa T; Yamamoto R; Shishido H; Yamamoto N
    Cancer; 2017 Apr; 123(8):1442-1452. PubMed ID: 27926777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROgnostic Model for Advanced Cancer (PRO-MAC).
    Hum A; Wong YKY; Yee CM; Lee CS; Wu HY; Koh MYH
    BMJ Support Palliat Care; 2020 Dec; 10(4):e34. PubMed ID: 30948445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.